Medline
$34.94Change from previous close: +0.69%Absolute change: +$0.24
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $47.01B
- Enterprise value
- $48.1B
- P/E (trailing 12 months)
- 43.7
- Forward P/E
- 22.2
- Price/book
- 2.65
- Price/sales
- 1.57
- EV/EBITDA
- 19.1
- EV/revenue
- 1.61
Profitability and growth
- Gross margin
- 25.1%
- Operating margin
- 0.8%
- Net margin
- 2.3%
- ROE
- 4.9%
- ROA
- 2.5%
- Revenue growth (year over year)
- 11.6%
- Earnings growth (year over year)
- 262.0%
Financial health
- Total cash
- $2.7B
- Total debt
- $12.64B
- Debt/equity
- 0.66
- Current ratio
- 4.33
- Quick ratio
- 2.45
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $44.54
- Median price target
- $45.00
- High price target
- $55.00
- Low price target
- $34.00
- Analysts with a price target
- 26
- Consensus
- Buy
- Forward EPS
- $1.58
- EPS estimate, current year
- $1.55
Shares and trading
- Average volume
- 7.35M
- Shares outstanding
- 877.35M
- Float
- 341M
- Institutional ownership
- 115.4%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 9.8%
- Short ratio (days)
- 6.28